Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment

BACKGROUND: Bortezomib is a proteasome inhibitor with minimal clinical activity as a monotherapy in solid tumours, but its combination with other targeted therapies is being actively investigated as a way to increase its anticarcinogenic properties. Here, we evaluate the therapeutic potential of co-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Taylor-Harding, B, Agadjanian, H, Nassanian, H, Kwon, S, Guo, X, Miller, C, Karlan, B Y, Orsulic, S, Walsh, C S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3261668/
https://ncbi.nlm.nih.gov/pubmed/22166800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados